Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

 

Get this Report



PayPal Verified Vendor

Rating

4.2 Star Rating for report Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review
4.2 / 5 stars rating
Pages: 25
Price: $300.00

Some of our Clients

Some Research and Expert Clients

Abstract

 
This comprehensive SWOT profile of Eurocine Vaccines AB provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eurocine Vaccines AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
 

Description

Eurocine Vaccines AB (Eurocine) is a clinical stage company which focuses on the development of protected nasal vaccines for influenza and pneumococci. Its product pipeline includes Immunose FLU, a safe and effective influenza vaccine for children. The company holds two proprietary adjuvant systems such as Endocine, and a Cationic System, both of which can be used for nasal vaccination. Eurocine uses clinically validated technology Endocine to develop protected nasal influenza vaccine for children. The company also develops nasal pneumococcal vaccine. It also out-licenses Immunose FLU for clinical development and commercialization. Eurocine is headquartered in Solna, Sweden.

Eurocine Vaccines AB Key Recent Developments

Apr 07,2017: Eurocine Vaccines strengthens organization to develop influenza vaccine
Oct 28,2016: Eurocine Vaccines initiates Phase I/II influenza vaccine study
 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH58321FSAActive Biotech AB (ACTI) - Financial and Strategic SWOT Analysis...May 2017
Report... 05IC-GDPH82389FSAOraSolv AB (OS) - Financial and Strategic SWOT Analysis ReviewJun 2017
Report... 05IC-GDPH1150415FSADiamyd Medical AB (DMYD B) - Financial and Strategic SWOT Analys...Aug 2017
Report... 05IC-GDPH351675FSACantargia AB (CANTA) - Financial and Strategic SWOT Analysis Rev...Aug 2017
Report... 05IC-GDPH82483FSAOasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT A...Aug 2017
Report... 05IC-GDPH81804FSAFeelgood Svenska AB (FEEL) - Financial and Strategic SWOT Analys...Aug 2017
Report... 05IC-GDPH208013FSAEnzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Rev...Aug 2017
Report... 05IC-GDPH61609FSAMedivir AB (MVIR B) - Financial and Strategic SWOT Analysis Revi...Aug 2017
Report... 05IC-GDPH308467FSAKancera AB (KAN) - Financial and Strategic SWOT Analysis ReviewAug 2017
Report... 05IC-GDPH82404FSAMedCap AB (MCAP) - Financial and Strategic SWOT Analysis ReviewAug 2017

Report Source Information

Supplied by: Research and Experts 
Date Published: 2017-08-07 

Report: Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

 

Contents

Table of Contents

Section 1 - About the Company

Eurocine Vaccines AB - Key Information
Eurocine Vaccines AB - Overview
Eurocine Vaccines AB - Key Employees
Eurocine Vaccines AB - Key Employee Biographies
Eurocine Vaccines AB - Key Operational Heads
Eurocine Vaccines AB - Major Products and Services
Eurocine Vaccines AB - History
Eurocine Vaccines AB - Company Statement
Eurocine Vaccines AB - Locations And Subsidiaries
Eurocine Vaccines AB - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Eurocine Vaccines AB - Business Description
Eurocine Vaccines AB - Corporate Strategy
Eurocine Vaccines AB - SWOT Analysis
SWOT Analysis - Overview
Eurocine Vaccines AB - Strengths
Eurocine Vaccines AB - Weaknesses
Eurocine Vaccines AB - Opportunities
Eurocine Vaccines AB - Threats
Eurocine Vaccines AB - Key Competitors

Section 3 - Company Financial Performance Charts

Eurocine Vaccines AB - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 

List of Tables

List of Tables

Eurocine Vaccines AB, Key Information
Eurocine Vaccines AB, Key Ratios
Eurocine Vaccines AB, Share Data
Eurocine Vaccines AB, Major Products and Services
Eurocine Vaccines AB, History
Eurocine Vaccines AB, Key Employees
Eurocine Vaccines AB, Key Employee Biographies
Eurocine Vaccines AB, Key Operational Heads
Eurocine Vaccines AB, Other Locations
Eurocine Vaccines AB, Subsidiaries
Eurocine Vaccines AB, Key Manufacturing facilities
Eurocine Vaccines AB, Key Competitors
Eurocine Vaccines AB, SWOT Analysis
Eurocine Vaccines AB, Ratios based on current share price
Eurocine Vaccines AB, Annual Ratios
Eurocine Vaccines AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 

List of Figures

List of Figures

Eurocine Vaccines AB, Performance Chart
Eurocine Vaccines AB, Ratio Charts
 

Scope

The profile contains critical company information including*,

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

 

Classification

Language Code: EN 
Region: Sweden 
Report Type: Company Reports 
Industry: Life Sciences 
Sector: Life Sciences 
Pages: 25 

Reasons to buy this report

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH58321FSAActive Biotech AB (ACTI) - Financial and Strategic SWOT Analysis...May 2017
Report... 05IC-GDPH82389FSAOraSolv AB (OS) - Financial and Strategic SWOT Analysis ReviewJun 2017
Report... 05IC-GDPH1150415FSADiamyd Medical AB (DMYD B) - Financial and Strategic SWOT Analys...Aug 2017
Report... 05IC-GDPH351675FSACantargia AB (CANTA) - Financial and Strategic SWOT Analysis Rev...Aug 2017
Report... 05IC-GDPH82483FSAOasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT A...Aug 2017
Report... 05IC-GDPH81804FSAFeelgood Svenska AB (FEEL) - Financial and Strategic SWOT Analys...Aug 2017
Report... 05IC-GDPH208013FSAEnzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Rev...Aug 2017
Report... 05IC-GDPH61609FSAMedivir AB (MVIR B) - Financial and Strategic SWOT Analysis Revi...Aug 2017
Report... 05IC-GDPH308467FSAKancera AB (KAN) - Financial and Strategic SWOT Analysis ReviewAug 2017
Report... 05IC-GDPH82404FSAMedCap AB (MCAP) - Financial and Strategic SWOT Analysis ReviewAug 2017

Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

Report 05IC-GDPH82491FSA has a rating of 84.2 percent
Figure of merit assessment for report 05IC-GDPH82491FSA

Relevance Rating

The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.

These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on

market interest - how often the report is viewed or purchased,
elapsed time - time since the report was published,
report detail - amount of detail in the report (pages, figures, images, comments etc.) and
price - the price of the report.


Regional Information

Taxonomy

Branch ID: 1532

Taxonomy Location

The taxonomy on the left shows the ancestors of the Sweden node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Sweden

Sweden is a strong industrialised economy whose main industries are telecommunications equipment, wood pulp and paper products, motor vehicles, pharmaceutical products, iron and steel. 

The recession in the eurozone has impacted on the Swedish economy but growth is expected in 2014. 

Researchandexperts.com is a  leading source of market research on Sweden.

Useful Links

World Bank Overview of Sweden

CIA World Factbook of Sweden

Sweden

Nordic Countries

Region

 

Europe

Fifty six sovereign states are listed with territory in Europe (six have limited rocognition). The 50 soverign states of Europe are Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark,  Estonia,  Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, The Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, Vatican City (Holy See).

The leading economies of Europe are Germany, France, UK, Italy and Russia.
 
Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the European region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in Europe, segmented at category level. Research and Experts reports also provide regional analysis and analysis of the leading companies in key European markets. 

Europe

Country

Countries

 

Industry Sector Information

Taxonomy

Branch ID: 205

Taxonomy Location

The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Life Sciences

The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive.  While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia. 

Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of  ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD. 

Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis. 

Useful Links

Analytical Life Sciences and Diagnostics Association

German Life Sciences Association

 

Life Sciences

Industry

Industries

 

 

Buy: Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

 

Item Code: 05IC-GDPH82491FSA

 
Licence: Single User
Price: $300.00
 
VAT: 0.0% 
Total: $300.00 

Feedback

Return to Research and Experts

Page created and rendered - Cache updated [1.72032s]

--